Exciting Frontier Beckons For Cancer Treatment

The U.S Food and Drug Administration (FDA) has created a new ‘breakthrough’ designation for cancer drugs, so that any that are deemed to be successful can effectively be fast-tracked through the trial process and brought to market quicker. Many respected physicians in the field of cancer research backed the move, including Robert Schneider of New [...]

List of New Cancer Drugs

As follows, here is a list of new cancer drugs that show especial promise. Herceptin or trastuzumab is a monoclonal antibody to the HER2 receptor and a recent innovation in breast cancer treatment.  In those who have the mutation specific to it, Herceptin can work impressively well.  At $100,000 per year of treatment, however, it [...]

Sutent or Sunitinib: Uses, Side Effects

Sutent - an exciting new cancer treatment Sutent, generic sunitinib, is a new cancer medication that has quickly become accepted as a first line treatment for renal cell carcinoma (RCC) as well as a treatment for gastrointestional stromal tumor (GIST) after resistance to imatinib develops. It is being investigated for other uses as well, like [...]

Tarceva: Drug Efficacy, Side Effects

Tarceva, generic erlotinib, is a new treatment for non-small cell lung cancer that works by targeting the epidermal growth factor receptor (EGFR).  It doesn’t work that great and can cost up to $50,000 a year.  As such, its class of medications has been reserved for second or third line treatment. Since lung cancer, however, typically [...]

Issues with Iressa or Gefitinib, Efficacy

Iressa or gefitinib targets epidermal growth factor receptor and disrupts its intracellular behavior.  This was hoped to have significant anti-cancer effects. Unfortunately, it seems increasingly that the clinical benefit of Iressa is limited.  Although it showed some benefit in treating certain types of cancer in certain populations, especially in people of Asian descent, as of [...]